Celerion will expand clinical operations to South Korea.
Celerion, a CRO for early clinical research and Applied Translational Medicine delivery, will expand clinical operations to South Korea through partnership with Seoul National University Hospital (SNUH).
The new Celerion office will be located within the SNUH Clinical Trials Center, and offers access to the 80-bed clinical research unit. It focus will be particularly geared toward clinical pharmacology, oncology, and pediatrics.
Read the full release here.